Peripheral/Endo

Corindus Receives FDA Clearance for CorPath® GRX System in Peripheral Vascular Interventions

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its CorPath GRX System in peripheral vascular interventions. The CorPath System is the first and only FDA-cleared […]

Cook Medical Realigns One-Third of Its Global Workforce to Better Support Customers, Enable Future Growth and Provide Opportunity for Employees

BLOOMINGTON, Ind.–(BUSINESS WIRE)– Today, Cook Medical announced key changes that simplify its organizational structure to better support customers. These changes realign the current sales, marketing, research and development, and customer service teams in addition to establishing new distribution channel management and medical education teams. The changes are a direct result of feedback […]

Cardiovascular Systems, Inc. Announces First Patients Treated from Radial Access Using Its Diamondback 360 Extended Length Peripheral Orbital Atherectomy Device

Feb. 14, 2018 12:00 UTC Device provides alternative access point to treat patients suffering from peripheral artery disease ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, announced today that the first patients were […]

Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device

LOS ANGELES, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) — Endonovo Therapeutics (OTCQB: ENDV) (“Endonovo” or the “Company”), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced positive results from a study of critical limb ischemia (CLI) in mice. Animals treated three times per day with the Company’s Pulsed Electromagnetic Fields (PEMF) […]

Cagent Vascular Presents Positive Results from the PRELUDE Study at LINC 2018

Feb. 7, 2018 14:30 UTC WAYNE, Pa.–(BUSINESS WIRE)– Cagent Vascular, a developer of next generation technology for vessel dilatation in cardiovascular interventions announces positive results from the First-in-Human PRELUDE Study. Dr. Andrew Holden (Auckland, New Zealand), Principal Investigator, presented 30-day and preliminary 6-month results using the FDA 510(k) cleared Serranator® Alto PTA Serration Balloon […]

Global Vascular Grafts Market 2017-2025 by Type, Material, and Application – Market Expected to Grow at 4.9% CAGR due to the Rising Prevalence of CVD

DUBLIN, Feb. 7, 2018 /PRNewswire/ — The “Global Vascular Grafts Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to ResearchAndMarkets.com’s offering. The global vascular grafts market was valued at US$ 2,352 million in 2016, and is expected to reach US$ 3,636.9 millionby 2025, expanding […]

Access Scientific Receives Innovative Technology Contract from Vizient, Inc. For POWERWAND Extended Dwell Catheters

SAN DIEGO–(BUSINESS WIRE)– Access Scientific announced it has received an Innovative Technology contract from Vizient, Inc. the largest member-driven health care performance improvement company in the country, for their POWERWAND Extended Dwell Catheter (EDC). The contract was based on a recommendation of POWERWAND EDC by hospital experts in this category who serve on one […]

LimFlow Taps a New Chairman of the Board and Expands Senior Management Team

LimFlow Nominates Pierre Guyot as Chairman of Board of Directors and Expands Senior Management Team PARIS–(BUSINESS WIRE)– LimFlow SA, a Paris-based medical device company dedicated to transforming treatment options for Critical Limb Ischemia (CLI), announced today changes to their board of directors by naming Pierre Guyot as the new chairman of […]

BTG plc Release: OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS Therapy For Pulmonary Embolism

BOTHELL, Wash.–(BUSINESS WIRE)– BTG plc (LSE: BTG), the global healthcare company, today highlighted OPTALYSE PE one year trial results, presented at the International Society on Endovascular Therapy in Florida. The findings confirm that bilateral pulmonary embolism patients treated in as little as 2 hours with a total tissue plasminogen activator (tPA) dose […]